Recent Finacing
Recent Raise
Bullet Biotechnology develops a personalized VLP-based active immunotherapy that conjugates patient-specific B‑cell lymphoma idiotype proteins and immune stimulants to train the immune system to target lymphoma cells.
Focus Areas
Total Raised
Funding round